General Information of the Compound
| Compound ID |
CP0847597
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
(2S,5S)-5-Ethyl-piperazine-2-carboxylic acid [(R)-2-(4-tert-butylcarbamoyl-4-cyclohexyl-piperidin-1-yl)-1-(4-fluoro-benzyl)-2-oxo-ethyl]-amide dihydrochloride
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C32H52Cl2FN5O3
|
||||||||||||||||||
| Molecular Weight |
644.704
|
||||||||||||||||||
| Canonical SMILES |
CC[C@H]1CN[C@H](C(=O)N[C@H](Cc2ccc(F)cc2)C(=O)N2CCC(C(=O)NC(C)(C)C)(C3CCCCC3)CC2)CN1.Cl.Cl
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C32H50FN5O3.2ClH/c1-5-25-20-35-27(21-34-25)28(39)36-26(19-22-11-13-24(33)14-12-22)29(40)38-17-15-32(16-18-38,23-9-7-6-8-10-23)30(41)37-31(2,3)4;;/h11-14,23,25-27,34-35H,5-10,15-21H2,1-4H3,(H,36,39)(H,37,41);2*1H/t25-,26+,27-;;/m0../s1
Show/Hide
|
||||||||||||||||||
| InChIKey |
NUGAYJJEISAXTE-IWVAZBPISA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound